Human Genital Melanocytes as Androgen Target Cells  by Tadokoro, Taketsugu et al.
Human Genital Melanocytes as Androgen Target Cells 
Taketsugu Tadokoro, Satoshi Itami, Ko Hosokawa, Hiroto Terashi,* and Susumu Takayasu* 
Department of Dermatology, Osaka University, Osaka, J apan; * I epanmem of Dennato logy, O ita M ed ica l Uni ve rsity, O ita, J apan 
As some parts of human skin- such as genital and areolar 
skin - become pigmented after puberty, melanocytes in 
these regions are thought to be sex honn.one target cells. 
We immunohistochemically localized androgen receptors 
in the nuclei of cultured hutnan genital melanocytes by 
monoclonal and polyclonal antibodies. When these cells 
were incubated with [1,2-3H] -testosterone, the major 
metabolite in the tnedium was dihydrotestosterone and 
Sa-reduction predominated over 17~-oxidation. Andro-
gen receptor and type I Sa-reductase tnRNAs could be 
I t is well known tl1ar the gen ital and areolar skin becomes pigmented after puberty and during pregnan cy (Snel l, 196-1). Although th ese changes of skin color are rho ughr to be mediated through humoral factors , the precise mechanism is not full y understood. M elanotropic ho rmones, such as a-m ebnocyte-
stimulatin g hormone (a-MSH) and ad renocorti cotrophi c hormo ne 
(ACT H), induce the darkenin g of human skin (Lern er and McGuire, 
'I 961 ; Lern er and M cGuire, 1 964), but plasma levels of these ho rmones 
do not ri se at puberty. In contrast, insuLin-like growth fa cto r (!G t=) -1 
shows an in crease of plasma levels at puberty (Grumbach and Styne, 
1 992), and is known to inAu ence the growth of melanocytes (H erl yn 
ct a/ , 1988). Plasma levels of sex hormon es change dramati cally in these 
periods. C ontroversy exists as to th e oestrogen recep tor statu s in normal 
human n1ebnocytes in spite of th e significant effects o f estrogens on 
these ce ll s Qee el a/ , "\994; M cleod eta /, 1994). Effects ofandrogens 
to melan ocytes i11 11itm have not been discussed after the report of skin 
darkenin g by inj ection of androgen (Hamilton and Hubert , 1938). 
In rhis study, in order to know whether human genital mebnocytes 
possess characteristics of androgen target cells. we studi ed inmwno histo-
chemi cal loca lizations of and rogen receptors (A R ) and m.easured 
the activities of Sa-redu ctase in these cell.s. Furthermo re, m\{.NA 
exp ressions of AR, type I and type II Sa-reductases were exa 111ined 
by reve rse transcriptase po lym.erase chain reactio n (i"l...T-PC R) and 
tyrosinase gene express ion was tes ted using north ern blot analysis. We 
also studied the effects of androgen on th e tyrosinase activities of 
human genital melanocytes. 
MATERIALS AND METHODS 
Culture of hun1a n genital melanocytes C ultured human genital mdano-
cytes were o btained fi·o m Cascade 13io logic Inc . (Po rtl:tnd , Orego n). The 
Manuscrip t rece ived N ove rn ber 26. 1 ')')(\; revised June 9 . 1997; accqJted fc) r 
publi cation June 24, '1997. 
R ep ri nt requests to: Dr. Satoslti ltarni , Departnrc llt of Dctmatology, Osab 
U niversiry, Osa ka 565, Ja pa n. 
Abbreviat io ns: AC TH. adrenocorti cotrophic ho rm o ne; a - MSH , 0',- m e\:mo-
cyte-stinru lating ho rm o ne; AR, androgen receptor; C A. cyprotero ne acetate; 
DHT, 5a-dihydrotestosteron e; IGF, in sulin- like growth f:1cro r; PI3S, phosp hate-
buffe red s:tlin e; PCR, po lym erase c hain reaction ; POM C, proopiontelanoco rtin; 
1<.188 '1, m ethyltri eno lo ne; 11.. T-PC R , reverse transcrip tasc pol ym e rase c hain 
reacti o n ; 1 7 ~-H SD, 17~- hyd ro~)'ste roid deh ydrogenase . 
detected in genital tnelanocytes by reverse transcriptase 
polymerase chain reaction. The tyrosinase activity was 
stimulated by the addition of androgen. This stimulation 
was antagonized by cyproterone acetate, whereas tyrosin-
ase 111.RNA expression was not affected by androgen. 
These results indicate that hun1an genital melanocytes 
are androgen target cells, and that androgen plays a 
role for pigmentation in the specific regional skin after 
puberty. Ke]' words: androgen l'ecepto•· I Sa-••eductase I tyrosin-
asellwrmone. J Invest Dermatol 109:513-517, 1997 
rne thods for c ulturing hUJnan m ekm ocyrcs ;u e described d se\·vh ere (P.irtdkow 
and . hipley, 1989) . Cells we re seri all y cul tured in se rum-free M C D\3153 
nr ediulll (K )'O kuto, T o kyo. Jap;r n) com aining 0.-+ ~Lg hydrocortison e per ntl, 
5 J..l g in sulin ptT ml , I ng bFGF per n1J, 50 J..l g bov i11 e pituitary ex tr~ ct per ml , 
I 0 ng pho rbol m yrisr:ne ace r:tte per ml , 6. 1 ).J g ethan o hmine per ml, 14.1 ).J g 
phosphoethano bmine per rnl , and 50 ).J g ampicillin p eT mi. All experim ents 
were perfo rm ed at th e fourth to six th subculture an d :lt conAu e ncy. 
Immunohistochemistry Mel:tnocytes \Vt"re cultured in M C D\3153 m ed ium 
containing I 0% feta l ca lf serum fo r 48 h , and were the n washed with phosphate-
bullo't·~d sa lin e (PUS), ai r- dried at 4°C for 30 min , and fixed with 2'Y., 
fo rmalde hyd e at roo rn te mperature for 2 min. A po lyclo nal artti- AR antibody 
(Mizobmi fl 11/, \99:2), whi ch W<ts kindly p rov ided by Dr. Mi zokami at the 
Univ<: rsity ofOccu pe1tiona l and Enviro m e ntal H ea lth , j apa n , w:1s used at 1:10011 
diluti o n in l'l3S cont:1 ining O.OS'Y., Tween-20 :1nd 1% bov ine serun1 albumin. 
A nr o noclo nal anti - A\1.. ami body (Chan g c1 rd. 1989a) . AN 1- 15 (Affinity 
BioReage m s, Go lde n , CO). was used at I 0 ~Lg per mi. Normal rabbit and rat 
se rurn we re used :lt th e S:l tne di lution :1s neg:ttive co ntro ls. Samples \:vere 
incubated with th e prirnary antibody overn ight at 4°C . Next, th e samples 
incub:1ted with th e pol yclo nal amibo d y were treated w ith a Dako LSAI3 kit 
(Dako, Carpime ria, CA) an d those incubated w ith the m o no clonal antibody 
were treated w ith pt..:roxid:lse-conjugar.ed rabbit anri - r:lt lg:G (O rgan o n T eknik:. , 
West C h ester) as th e secondary :.\ntibody. Peroxidase n.::tc ti o n products were 
visuali zed wi th 3.3' -diamino bcn zidinc. 
Androgen metabolism At subconAu cncy, the m editnn was rep!Jcecl w ith 
M CD U I 53 rn ediurn conta.ining .10% fet:J I ca lf serum. Aft,"· 48 h , cdls we re 
washed with M C DB 153 m ediun1 and incubated wit h 25 nM l1 .2-·\ -IJ -
tesrostc ro nt• in M C DB 153 m edium for 2 h at 37°C in 5% C02. After 
inc ub:ttion. a 4- to ld vo \unre of chlorolorn Hllethan o l (2 / I , vo l/ vn l) (Fnlch ctol, 
I ')57) containin [!; I 0 ~l g c:1 ch o f ca rri er stero ids wos added to th e m edium. The 
extracted steroids were ana lysed by thin b yer chro m:Jtography w ith th e so \ve llt 
svste rn 11\ e thanol: ch lo rofonn ( I :99) as described previo usly (Gomez and Hsie1 , 
1,9(18). The purity of androst3nedio l after acety lati o n was determin ed by thin 
la yer chromatograp hy w ith th e solvent sy~ tem be nzene:ethylcrher (4: '1 ). The 
purity of othe r ste ro ids \V:ls d e tcn11in ed by hig h pcrforni :III C~ liquid chroJnaro-
(!;raph y as previo usly reported (Th ei rr tz <' I a/ , 1989; Sono da <'I a/ , 19\JJ) . The 
:1c ti viry o f So:.-n:ducrase was calc ulated ft-ont the.:.· $Lilli of 5a-di hydrotestoste:rone 
(DHT), androstanediol, androstan edion e, and androste ro ne form ed ami tha r o f 
1 7 ~- h ydroxystero id de hydrogenase ( 1 7 ~-HSD) li"or tt rite sunr of androstene-
di o ne , androsr:1n edio ne, :.1 11d androsrc: ro ne, ;.1s testoste ro ne is 111 erabo lized to 
\JHT by Sa-reductase and then to and rosta ned io l and androsta nedi o nc or to 
androste nedione by 1 7 ~- H SD, to androsta nedione by 50',-redu ct:tse. and th e n 
to ~ndrostero n c. 
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Figure 1. Detection of ARs in the nuclei of human 
melanocytes. Human genital melanocytes were 
incubated with a polyclona l anti-AR. antibody (11) and 
norma l rabbit serum (b) as a negative controL ARs 
were de tected in the nuclei of human genitol 
melanocytes. Scale bar, 50 ~1 111. 
Determination of protein concentration T he cells were washed and lysed 
with .4 ml of 0.5 N NaOH . T he protein content was determi ned by the 
BIO-H.AD Prote in Assay kit (B io-Rad LaboratOJies, Ri chm ond , CA). 
RT-PCR SubconAu ent no elanocytes were cultured fo r 48 h in MC DD153 
medium containing 2% feta l calf st:rum w ith ·1 o-v M m ethyltrienolone (RJ 881 ), 
a potent syntheti c and rogen, and/o r 10- 7 M cyprote rone aceta te, a potent AR 
antagonist. After incubatio n, total I~A was isohted by the acid guanidiniurn 
thiocyanate-p henol-chlorofo rm method ( homczynski and Saccbi , 1987). 
eD NA was gene rated from total I:Z.NA as previously described (!rami et of, 
1995b). Briefl y, 400 ng of total l:Z.NA was reverse transc ribed in a fina l volume 
of 20 f.LI containing: 2.5 U M- M.LV reverse transcriprase (G ibco BKL, 
Ga ithersburg, MD) per !Jl, 1.0 U RNase inhibitor (Takara, Tokyo, Japa n) per 
fll , 1 rnM dNTP mix, 2.5 !JM random bexamers, 10 mM Tris- HC I, 5 mM 
M gCJ2, and 50 mM KC J. The mixture was preincubated at room temperature 
for 10 min fo ll owed by 42°C for 45 min , 99°C for 5 min , th en 5°C for ·1 0 min. 
Amp lifi ca tio n by polymerase chain reaction (PC R ) was performed as fo llows. 
Fi ve rn.i cro liters of each eD NA mixture was added to a to t;tl of 25 fll reaction 
mixture containing 10 mM T ris-HC I, 2 rnM MgCJ2, 50 mM KCI, 0.2 mM 
each pair of priming oligomer, and 0.025 U recombinant Taq DNA polymerase 
(Takara, Tokyo, Japa n) per j.J.I , using a DNA thermal cycler (Astec , Fukuoka, 
Japan). A cycle profi le consisted of 45 s at 95°C, 45 s at 60°C, and 1 min ;tt 
72°C. Thirty-five cycles we re perfo rmed for AI<. and type I Sa-reductase, 45 
cycles fo r type II Sa-recl ucta.se, and 20 cycles for tyrosinase and G3PDH. T he 
products were analysed on 2'){, aga rose gel electrophoresis and their sizes we re 
compared w ith 1 00-bp molecular weight markers (G ibco BRL, Go ithersburg, 
MD). Each product was diges ted with restri cti on endonuclease to confirm its 
identi ty. The oligonucleotide prilll ers for P C I<. were based on published 
m.RNA sequences and we re as follows: human .AR (Chang et al, 1988), 5 '-
GGTAAGGGAAGTAGGTGGAA-3' and 5'-CCT TCTAGCCCTTTGGT-
GTA-3'; human type I Sa-reductase (Andersson and Russell , '1990), 5'-
TTACCCGTTT CT ATG CGAG-3 ' and 5'-GTTCTCCACTTACACAC-
AGC-3'; human type l1 Sa-rede~c tase (Andersson ct a!, 1991), 5' -GGCCTCTT-
CTGCGTACATTA-3 ' and 5'-CTA AGAAG CAA CT GT CGCCA-3'; human 
ty rosinase (S hibahara ct ,,{, 1988; Takeda ct a/ , '1989) , 5' -GAGAAGGAATG-
CTGTCCACC-3' and 5'-GTTGTACTCCTCCAATCGGC-3 ' ; and human 
glyceraJdebyde-3-phosphatc dehydrogenase (G3 PDH) (Tso cr rd. 1985), 5'-
CCCATCACCATCTTCCAG-3' and 5' -CCTGCTTCACCACCTTCT-3'. 
Northern blo t analysis Five micrograms of to ta l cell ular I'Z.NA f:i-om gen ital 
melanocytes was electrophoresed on I% aga rose gel conta ining 2.2 111 formalde-
hyde and transfered to a nylon membrane (Pos itively C harged, Boehringe r, 
Mannheim , Germany) . eDNA probe for hu man tyrosinase in the PC K produ cts 
was labeled with D IG-High Prime (Boehringer) and 100 ng per ml D IG-D NA 
probes were hybridized to the blots for 17 h at 37°C. T he blots we re processed 
with 150 mU antidigoxigenin - AP (Boehringe r) per ml according to the 
manufacturer 's method and developed with a chemiluminescence kit (Boehr-
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inger M annheim). The density of tyros inase mRNA was examin ed relative to 
that of 28S ribosoma ll~A (Harada ct a/, I 993). 
Mcasuren1ent of tyrosinase activity TyrosinJse activity was meas ured by 
the ox idatio n of L-dopa (Maeda c/ rrl, 1992; Takahashi and Parsons, 1992; 
Du ffey cl a!, 1994; Hunt ct rr /, 1994). SubconAuent melanocytes were trea ted 
with 'I o-v M R 188 :1 with or: without I o-7 M cyproterone ace tate in MCDB1 53 
medium containing 2% feta l calf serum fo r 96 h. After the trea tment, cells were 
harvested with 0.25% trypsi n-EDT A and 1 X I 06 cell s were resuspended in 
100 fl .\ of 50 mm ph osphate buffer (pH o.S) containing ·1% Trito n X-1 00 (wt/ 
vo l). T hey were rapidly frozen by placing them in a -70°C fi·eezer for 30 min, 
and subsequently allowed to thaw at room temperature ro ensure complete 
disru ptio n. T he aliquo ts (3 X 30 ~II ) we re subjected to centrifugation at 15 ,000 
rpn1 for '10 1nin and the pell ets were mixed with 1 ()() ~-tl of I 0 mM L-dopa in 
50 mM phosplt ;~te buff'e r (pH 6.8) in a 96-well plate. T he abso rbance was read 
at 490 nm on the EU SA scanner (My reader 7, Sanko Ju nya ku, Japan) at roo m 
temperature every 5 m i11 fo r 120 min. Tyros inase acti vity was expressed as the 
increase in O D at 490 nm per min per wel l. 
RESULTS 
Detection of AR in the nuclei of hnrnan genital 
tnelanocytes N uclei of cultured human genita l m ebnocytes were 
positi vely stained with the polyclonal anti-Ail.._ antibody (Fig 1a), but 
were negati ve with normal rabbit serum (Fig tb). T he sam e results 
were obt;1i11ed w hen the monoclonal anti-AR antibody was used (data 
not show n). Alth ough nongenita l m elanocytes ·were also isolated and 
examined using these antibodi es, they were only weakly stained. 
T herefore, we did not cnndu ct further experiments on th ose cells. 
Comparison of Set-reductase activities and 17~-HSD 
activities W e next examined the metabolism of testosterone by 
cultured human genita.lmelanocytes . W hen human genitalmebnocytes 
were incubated with 2S nM [1,2-3H] -testosterone, whi ch approximates 
a p lasma level of tes tosteron e in the adu lt male, DHT formation was 
linea r during the in cubation for 4 h in our preliminary experiment. 
T herefore, the amoun t of metaboli tes form ed was measured after 2 h 
o f in cubati on. DHT was dominant over other metaboli tes (Fig 2). 
T he activities of Sa-redu ctase and 17~-HSD of cultured hu m.an genital 
melanocytes in three ind i v idu ~1l s are summarized in Table I . Human 
genital melanocytes metabolized testosterone m ore actively to DHT 
than to androstenedio ne. 
Expression of AR mRNA and type I Set-reductase mRNA We 
also examin ed the expressio ns of AR, type l and type ll Sa-reductase 
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Figure 2. Genital melanocytes predominantly n1etabolize testosterone 
to DHT. Metabolites o f testosterone in hu111 an genital 111danocy tes ore shown. 
Melanocytes were incuba ted with 25 nM II ,2-31-1]- testostcrone fo r 2 h. T he 
llletabolites were anal ysed by thin lo y<'r chro111atograph y and high pcrforn1ance 
liquid chro nw tograph y. Each value is the m<;a n o f two dcter111in ati ons. Si111ilar 
results were obtained in fo ur sam ples. AAIJ , Sa-androstaned ione; t.\ 
and rostened io ne; Aro ne, and rosterone; dial, androst;"tn edi o l. 
Table I. Sa-R ed u ctase and 17~-hydroxysteroid dehydrogenase 
activities in hun1a n l?enital melanocytes 
Sa.- I<.." Sa- l<.. / 17B- HSD' 
Genital nwl:uwcytes ll. ~ 78 ::': 0.036" 0.129:!: 0.00 1<1 3.7 17 ::': 0.2K7" 
'' 5a- lt, Scx-n::duct::lse activi ty. 
b 17P- HSD, 17P-hydroxyswroid dchydro~c 1me ac ti vity. 
r T he r:.tio of Sa - reductio n t·o ! 7 ~-oxid:nion of testostero ne. 
" E:u:h v:llll c is ::1 me:111 ± SEN\ of thn.:t c:1sc.:s . l'Xpressed ;-~s pmo lc.:s pi.:r rng prote in per h. 
mR . .NA in human genital m ebnocytes. R T- PC R ana lysis revealed th at 
th ey signi fi can tly expr<;:ssed AR ml~A and typ e I Sa-redu c tase 
mR.NA, but no t type ll Sa-red uc tase m l~NA . N either JU 88 1 no r 
cyprotero ne ace ta te affected th e express io ns o f AR, type 1 Sa-reduc tase 
and tyrosinase mRNA (Fig 3). 
Northern a nalys is H ybridi zatio n of th e no rth e rn b lo t comainin o- S 
/Jg of total ce llular l~NA from human genital m elan ocytes with ~1 e 
D IG -DNA probe for ty rosinase showed specific tyrosinase mRNA. 
No signifi cant diffe re nces o f mRNA expressio n were found be twee n 
co ntrol , rl- 1. 88 1-treatcd , and 1<..'1 88 '1 p lus cyp ro te ro ne aceta te- rreawd 
cells (F ig 4). 
Increase of tyrosinase activities by a ndrogen We also studied 
th e effec ts of androgen o n the g rowth o f m ehnocytes and 0 11 t he 
tyrosimse acti vities of th e cu ltured m elan ocytes. Neith e r R.l 88 '1 n o r 
cyprote ro n e ace tate sh owed signifi cant effects o n the ceLl g rowth of 
human geni ta l mel anocytes (da ta no t shown). In contrast , as shown in 
F igS , th e ty ros in ase ac t ivity was signifi cantl y in c reased by the add itio n 
of 10- 9 m 1<..1 881 (p < 0.002) w he n co nq ared with contro l. 10- 7 m 
cypro te ro ne ace ta te a ntago 1~.izcd th e K 188 .1- indu ced in c rease o f the 
ty ros inase a ·ti v iry (p < 0 .0006). 
D ISCUSS ION 
T he present o bse rvatio ns ind icate tha.t hun1 an genital melanocytes 
possess sc~era l characte risti cs of androgen target ce lls. AKs were 
imnwno )oca li zed in the ir nucle i. T h e in tranuclear loca li zation of A l'l..s 
MELANOCYTES AS ANDR OGEN TA I"GET CELLS SlS 
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Figure 3. E xpressions of mRNAs of AR and type I Sa~red u ctase were 
not affected by androgen . Ex f>ressions of 111 l'l...NA of A11.. , rype I Sa - reductase 
(Sa- l), type II Sa - reductase (Sa - 11), ryrosin :~se (Tyr), ond G3PI 1-1 (G3) in 
cu lrurt•d human ge nital mdanocyres :t n~ shown. Cells were cu ltured in the 
fJrese nce of 10- '1 M RI S, I (lan es 2, 6, 10, 1-1 , 18) or 10-9 M 1<.. 1881 ond 
Jn-7 M cyproterone acetate (/,Illes 3, 7, II , 15. 19). Control (fanes I , 5, 9, 13. 
r T) was treoted with vehicle (0 . 12'Y.•) :~ l on e. Beo rd danJnl pop illo cel ls (lm~e:s -1 , 
', 12, 161 20) \Ve rc included as positi ve contro l of androgen ta rget cells. M, 
size 111 arkers ( I 00-bfl ladde r, C ibco Bll..L. Go ithersburg, MD). R esu lts of one 









Figure 4 . Tyrosinase mRNA level was not changed by androgen. (•1) 
Torol 11..NA (5 ~lg per hne) harvcsteclli-om hu111 :111 geni tal lll d:~nocytcs cultured 
in the presence of I o-9 M R.188 1 (lane 2). 10- 9 M R 188 1. and I o-7 M 
cyfJrOterone ocetote (/'""' 3), or vehide (!1. 12%) alone os a comrol (lane /) was 
blotted ond hyb rid ized with a DIG-DNA probe. The --7 indica tes the size of 
;he 2i:lS and ISS rib so m:JI ltNA. (I>) Equol loading of the l :~ncs was confirllled 
by sto ining 185 ribosomoJ rtNA with nJethykn e blue. 
is confirmed in typica l t~ rge t ceLls, such as th e prostate , se minal vesicles, 
sebaceous glands, and beard de rmal papi lla ce lls (C hang c1 a/, 1989b ; 
l'l...ui zeveld d e W im er c1 a/, 1991 ; ltami c/ a/, J99Sa) . In addition , they 
lll e tJbolized testOste ro ne m ore acti vely to DHT than to J ndrosre nc-
dion e, sh owin g a hig h ratio of Sa - redu cti o n to 1 7 ~-ox i dati o n of 
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Figure 5. Tyrosinase activity of hun1an genital melanocytcs increased 
by androgen . Effect o f methyltrienolonc (R 1881) and cyproterone acetate on 
the tyrosinase acti vity of hu man genital mebnocytes is shown . Cells were 
cultured in the presence of 10-9 M RJ 881 or with both lo- Y M R :l88 '1 and 
10-7 M cyproterone acctnte (R + C A) for 96 h. Control cell s were cultu red with 
vehicle (0.12'Y.•) alone. In each case, the mean ± SEM of three determinations is 
shown fi·orn one of three experiments that gave similar resul ts. T he significance 
of differences was assessed by tbe two-tail ed Student's t test. *p < 0.002, 
**p < 0.0006. 
testosterone, li ke cultured dermal papilla cells (ltamj el a/, 1990). We 
also demonstrated th e c)'pression of AR and type I Sa-reductase 
mR.NA by human genital melanocytes, but not type II. Although 
type I I Sa-reductase is generally a prerequisite for male phenotypic 
expression (Andersson et al, 199 1; Wilson et a/, ] 993), th e sebaceo us 
gland li01n th e scalp skin (Thiboutot el a/, 199S) :llld the pubi c skin 
(Mestayer r:t al, :1996) predominantly expresses type I Sa-reductase. 
T herefo re, it is possib le that type I Sa- redu ctase also mediates andro-
genic effects in several kinds of cells including hum an gen.ita.l melan-
ocytes. 
In the present study, the expression of AR and type I Sa-red uctase 
mR.NA did not appear to be regu lated by androgen, beca use neith er 
R.1 ·1 nor cyproterone acetate :1ffected their expression. Previous 
repo rts showed upregulati on of AR in the rat prosta te (Takeda et a/, 
199 '1) and type I Sa-1·eductase of pubi c skin (Mowszowicz et a/, 1983) . 
Whether effects of androgen on AR and Sa-reductase differ by cell 
types remains unknown. 
T he current study showed that and rogen stimuhted th e tyrosi nase 
acti vity of human genital melanocytes, alth ough it did not affect their 
ce Ll growth and th e ex pression of tyrosi nase mRNA. As cypro terone 
acetate antagoni zed this stimulatory effect of androgen , the effect was 
likely to be mediated by th e AR. pa th way. This upregula tion of 
the tyrosinase activity by androgen may be determin ed by post-
transcripti onal events and/or by participation of other co-fuctors 
(Naeyaert et a/, 199 1; lozumi et a/, 1993), because an androgen 
responsive element has not been identified in th e promoter region of 
the human tyrosinase gene (Giebel ct a/, 1991; Ponnazhagan et a/, 1994). 
Ph ysiologicall y, gonadal androgens ;1re considered to be responsible 
for skin pigmentation in the gen.ita.l and areolar areas, because cas tration 
of men results in decreased skin pigmentation and administration of 
androgen ca uses skin darkening of these regions (Ha milton and Hubert, 
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1938). High concentrations of androgens in these locali zed areas 
possibly play a key role in the sk in darkening (Deslypere and Verm eulen, 
198S). In women, adrenal androgens, w hich are uti.li zed as precursors 
of testosterone and D HT, may be important fo r skin pigmentati on of 
these areas, as in the case of deve lopment of the sebaceous gland during 
puberty (Pochi et a/, 1977; Long cope, J 986). Severa.! oth er fu ctors are 
also considered to increase the pigmentation of hum an skin. Recent 
work has shown that melanotropi c hormones such as a - MSH and 
ACTH have mitogenic and melanogenic effects in vitro by binding to 
and activating melanocortin receptors (Abdei-Malek eta /, '1 99S; Suzuki 
eta/, J 996). In addition , human ski n can exp ress proopiomebnocortin 
(POMC) and POMC-deri ved peptides (Slominski et a/, 1993). The 
local levels of POMC and POMC-derived peptides may be mu ch 
higher than th eir serum levels (G ilchrest et a/, 1996); however, the 
plasma ACTI-l level does not rise at puberty (Apter el a/, 1979), and 
it has not been cbt-ifi ed whether loca l levels of POMC and POMC-
derived peptides increase at this time. AJthough plasma levels of LH 
and FSH increase at puberty (G rumbach and Styne, 1992), their direct 
effects on human m elanocytes are not clear (Meyskens and almon, 
1981; Perez el a/, 1983). Growth horm ones also mi ght affect the 
growth of melanocytes directly or thro ugh lGF-1 . Human melanocytes 
express mRNAs of growth horm one receptor and IGF-1 by R.T-PCR 
(Tavakkol ct a/, 1992) . Expression ofiGF-1 is also detected in pigmented 
nevi and mela nomas by iu situ hybridiza tion and immunohistochemistry 
(Fleming et a/, 1994). Clinica l observation revealed that nevi of children 
rapid ly grow during growth ho rmon e therapy (Bou rguignon et a/, 
1993) and that both dysplasti c nevi and common nevi tend to enlarge 
during pregnancy when growth horm one levels are high (Sanchez 
ct a/, 1984; Ellis , 1991; Rudd, 1991). 
In conclusion, ou r present findin gs show that human geni ta l melano-
cytes are target cells fo r an drogen, which stimulates tyros in ase activity 
in these cells at puberty. Accordingly, androgens and other ho rm ones, 
such as growth hormone/ IGF-1 and POMC/POMC-deri ved peptides, 
may <let cooperatively to increase the pigmentation of androgen-
sensitive skin at p uberty. 
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